CHRISTOPHER JONCAS: Open Payments
NPI 1336136456 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,660 in 40 payments from 8 companies in 2025. Trend: 2023 $23,246 · 2024 $33,576 · 2025 $25,660
Speaker / faculty: $15,190Consulting: $6,375Travel & lodging: $2,582Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 32 | $25,501 |
| Lundbeck LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: INGREZZA, REXULTI, Rybelsus, SHINGRIX, XIFAXAN, ZORYVE, INSPIRE.
Industry payments across MA — which companies pay providers there.
